Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.


There is considerable variation in the level of toxicity patients experience for a given dose of radiotherapy, which is associated with differences in underlying individual normal tissue radiosensitivity. A number of syndromes have a large effect on clinical radiosensitivity, but these are rare. Among non-syndromic patients, variation is less extreme, but equivalent to a ±20% variation in dose. Thus, if individual normal tissue radiosensitivity could be measured, it should be possible to optimise schedules for individual patients. Early investigations of in vitro cellular radiosensitivity supported a link with tissue response, but individual studies were equivocal. A lymphocyte apoptosis assay has potential, and is currently under prospective validation. The investigation of underlying genetic variation also has potential. Although early candidate gene studies were inconclusive, more recent genome-wide association studies are revealing definite associations between genotype and toxicity and highlighting the potential for future genetic testing. Genetic testing and individualised dose prescriptions could reduce toxicity in radiosensitive patients, and permit isotoxic dose escalation to increase local control in radioresistant individuals. The approach could improve outcomes for half the patients requiring radical radiotherapy. As a number of patient- and treatment-related factors also affect the risk of toxicity for a given dose, genetic testing data will need to be incorporated into models that combine patient, treatment and genetic data.

DOI: 10.1016/j.clon.2015.06.013

3 Figures and Tables

Citations per Year

Citation Velocity: 16

Averaging 16 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Barnett2015IncorporatingGB, title={Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.}, author={Gillian C. Barnett and Sarah Kerns and D J Noble and A M Dunning and Catharine M. L. West and Neil G. Burnet}, journal={Clinical oncology (Royal College of Radiologists (Great Britain))}, year={2015}, volume={27 10}, pages={579-87} }